EUVIMEDEUVIMED entdecken
Crossref

Peripheral cancer attenuates amyloid pathology in Alzheimer’s disease via cystatin-c activation of TREM2

Xinyan Li, Xiaomei Tang, Jinyu Zeng, Limin Duan, Zhenye Hou, Lanfang Li, Yiqing Guo, Changdong Chai, Jiahao Liu, Ya Wang, Ling-Qiang Zhu, Hao Li und 4 weitere

Cell · 2026-02 · 189 (3) · 853-871.e31

DOI: 10.1016/j.cell.2025.12.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-02. Verfasst von Xinyan Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for Brain Medical Sciences and School of Basic Medicine, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, Immunologic, Membrane Glycoproteins, Cystatin C. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: Huazhong University of Science and Technology, National Natural Science Foundation of China, Ministry of Education of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) and cancer are among the most devastating diseases worldwide. Epidemiological data indicate that the incidence of AD significantly decreases in patients with a history of cancer. However, whether and how peripheral cancer may affect AD progression is yet to be studied. Here, we find that peripheral cancer inhibits amyloid pathology and rescues cognition via secretion of cystatin-c (Cyst-C), which binds amyloid oligomers and activates triggering receptor expressed on myeloid cells 2 (TREM2) in microglia, enabling microglia to degrade the pre-existing amyloid plaques in AD mice. These effects of Cyst-C are abolished by a cell-type-specific deletion (Cx3cr1TREM2-/-) or mutation of TREM2 (TREM2R47H) or Cyst-C (Cyst-CL68Q) in microglia. Together, these findings provide significant conceptual advances into cancer neuroscience and establish therapeutic avenues that are distinct from the present amyloid-lowering strategies, aiming at degrading the existing amyloid plaques for precision-targeted AD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReceptors, ImmunologicMembrane GlycoproteinsCystatin CAnimalsMicrogliaHumansMicePlaque, AmyloidAmyloid beta-PeptidesMice, Inbred C57BLAmyloid

Stichwörter der Autor:innen

Alzheimer’s diseaseTREM2amyloid pathologycancer neurosciencecystatin-cperipheral cancer

Substanzen

Receptors, ImmunologicMembrane GlycoproteinsCystatin CTrem2 protein, mouseAmyloid beta-PeptidesTREM2 protein, humanAmyloid

Autor:innen und Institutionen

  • Innovation Center for Brain Medical Sciences and School of Basic Medicine, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Intensive Care Unit, Union Hospital, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of Gynaecology and Obstetrics, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Innovation Center for Brain Medical Sciences and School of Basic Medicine, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: lym@hust.edu.cn.

Förderung

  • Huazhong University of Science and Technology
  • National Natural Science Foundation of China
  • Ministry of Education of the People's Republic of China
  • Wuhan Union Hospital

Zitieren

APA

Li, X., Tang, X., Zeng, J., Duan, L., Hou, Z., Li, L., Guo, Y., Chai, C., Liu, J., Wang, Y., Zhu, L. Q., Li, H., Zhang, T., Wang, Y., He, A., & Lu, Y. (2026). Peripheral cancer attenuates amyloid pathology in Alzheimer’s disease via cystatin-c activation of TREM2. Cell, 189(3), 853-871.e31. https://doi.org/10.1016/j.cell.2025.12.020

Vancouver

Li X, Tang X, Zeng J, Duan L, Hou Z, Li L, et al. Peripheral cancer attenuates amyloid pathology in Alzheimer’s disease via cystatin-c activation of TREM2. Cell. 2026;189(3):853-871.e31. doi:10.1016/j.cell.2025.12.020

BibTeX
@article{Li2026,
  author = {Li, Xinyan and Tang, Xiaomei and Zeng, Jinyu and Duan, Limin and Hou, Zhenye and Li, Lanfang and Guo, Yiqing and Chai, Changdong and Liu, Jiahao and Wang, Ya and Zhu, Ling-Qiang and Li, Hao and Zhang, Tongmei and Wang, Yue and He, Aodi and Lu, Youming},
  title = {Peripheral cancer attenuates amyloid pathology in Alzheimer’s disease via cystatin-c activation of TREM2},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {3},
  pages = {853--871.e31},
  doi = {10.1016/j.cell.2025.12.020}
}
Kostenlos starten →